Discovery of the inhibitors of tumor necrosis factor alpha with structure-based virtual screening.

Tumor necrosis factor alpha (TNF-α) has been considered as one of the attractive drug targets for allergic diseases including asthma. We have been able to identify five novel TNF-α inhibitors with a drug-design protocol involving the structure-based virtual screening and in vitro cell-based assay for antagonistic activity. Because the newly discovered inhibitors are structurally diverse and have the desirable physicochemical properties as a drug candidate, they deserve a further investigation as anti-asthmatic drugs. The interactions of the identified inhibitors in the binding site of TNF-α dimer are addressed in detail to understand the mechanisms for the stabilization of the inactive dimeric form of TNF-α.

[1]  P. Barnes,et al.  Parameters associated with persistent airflow obstruction in chronic severe asthma , 2004, European Respiratory Journal.

[2]  P. Schafer,et al.  Discovery of (S)-N-[2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl] acetamide (apremilast), a potent and orally active phosphodiesterase 4 and tumor necrosis factor-alpha inhibitor. , 2009, Journal of medicinal chemistry.

[3]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .

[4]  J. Howbert,et al.  Identification of TNF-alpha inhibitors from a split-pool library based on a tyrosine-proline peptidomimetic scaffold. , 2003, Bioorganic & medicinal chemistry letters.

[5]  S. Wenzel,et al.  Relationship of small airway chymase-positive mast cells and lung function in severe asthma. , 2005, American journal of respiratory and critical care medicine.

[6]  J. Gasteiger,et al.  ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .

[7]  J. Gasteiger,et al.  Automatic generation of 3D-atomic coordinates for organic molecules , 1990 .

[8]  Hwangseo Park,et al.  Critical assessment of the automated AutoDock as a new docking tool for virtual screening , 2006, Proteins.

[9]  I. Kuntz,et al.  Ligand solvation in molecular docking , 1999, Proteins.

[10]  F. Brunelle,et al.  Thoracic CT in pediatric patients with difficult-to-treat asthma. , 2002, AJR. American journal of roentgenology.

[11]  R. Djukanović,et al.  The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  Lyle L. Moldawer,et al.  Anti-TNF-α therapies: the next generation , 2003, Nature Reviews Drug Discovery.

[13]  S. Puddicombe,et al.  Epithelial-mesenchymal interactions in the pathogenesis of asthma. , 2000, The Journal of allergy and clinical immunology.

[14]  Jun Wang,et al.  Small-Molecule Inhibition of TNF-α , 2005, Science.

[15]  C. Sander,et al.  An effective solvation term based on atomic occupancies for use in protein simulations , 1993 .

[16]  Biswanath De,et al.  Development of N-2,4-pyrimidine-N-phenyl-N'-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-alpha) synthesis. Part 1. , 2006, Bioorganic & medicinal chemistry letters.

[17]  K. Chung,et al.  Neutrophilic inflammation in severe persistent asthma. , 1999, American journal of respiratory and critical care medicine.

[18]  Hwanho Choi,et al.  Prediction of Molecular Solvation Free Energy Based on the Optimization of Atomic Solvation Parameters with Genetic Algorithm , 2007, J. Chem. Inf. Model..

[19]  Biswanath De,et al.  Development of N-2,4-pyrimidine-N-phenyl-N'-alkyl ureas as orally active inhibitors of tumor necrosis factor alpha (TNF-alpha) synthesis. Part 2. , 2006, Bioorganic & medicinal chemistry letters.

[20]  Jongki Hong,et al.  New jasmonate analogues as potential anti-inflammatory agents. , 2008, Bioorganic & medicinal chemistry.

[21]  C. Suphioglu.  Analysis of immunoglobulin E‐mediated responses in central Africa , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[22]  S. Holgate,et al.  The mechanisms, diagnosis, and management of severe asthma in adults , 2006, The Lancet.

[23]  T. Arrhenius,et al.  Novel chromene derivatives as TNF-α inhibitors , 2003 .